49 related articles for article (PubMed ID: 3404264)
1. Synthesis and comparative biodistribution of the desferrioxamine-human serum albumin (DF-HSA) conjugates prepared with various methods.
Jánoki GA; Harwig JF; Wolf W
J Nucl Med Allied Sci; 1988; 32(1):39-44. PubMed ID: 3404264
[No Abstract] [Full Text] [Related]
2. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
3. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
[TBL] [Abstract][Full Text] [Related]
4. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
Hashmi M; Rosebrough SF
Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
[TBL] [Abstract][Full Text] [Related]
6. [67Ga]desferrioxamine--HSA: synthesis of chelon protein conjugates using carbodiimide as a coupling agent.
Janoki GA; Harwig JF; Chanachai W; Wolf W
Int J Appl Radiat Isot; 1983 Jun; 34(6):871-7. PubMed ID: 6874113
[TBL] [Abstract][Full Text] [Related]
7. Gallium-68 labeling of albumin and albumin microspheres.
Wagner SJ; Welch MJ
J Nucl Med; 1979 May; 20(5):428-33. PubMed ID: 120419
[TBL] [Abstract][Full Text] [Related]
8. Preparation of 18F-human serum albumin: a simple and efficient protein labeling method with 18F using a hydrazone-formation method.
Chang YS; Jeong JM; Lee YS; Kim HW; Rai GB; Lee SJ; Lee DS; Chung JK; Lee MC
Bioconjug Chem; 2005; 16(5):1329-33. PubMed ID: 16173815
[TBL] [Abstract][Full Text] [Related]
9. A facile method for the labeling of proteins with zirconium isotopes.
Meijs WE; Haisma HJ; Van der Schors R; Wijbrandts R; Van den Oever K; Klok RP; Pinedo HM; Herscheid JD
Nucl Med Biol; 1996 May; 23(4):439-48. PubMed ID: 8832698
[TBL] [Abstract][Full Text] [Related]
10. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Bures L; Bostík J; Motycka K; Spundová M; Rehák L
Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
[TBL] [Abstract][Full Text] [Related]
11. The use of electroimmunoassay for the determination of the in vivo stability of labelled proteins.
Jánoki GA; Körösi L
Nucl Med Commun; 1988 May; 9(5):339-45. PubMed ID: 3412726
[TBL] [Abstract][Full Text] [Related]
12. Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agent.
Motta-Hennessy C; Eccles SA; Dean C; Coghlan G
Eur J Nucl Med; 1985; 11(6-7):240-5. PubMed ID: 4076230
[TBL] [Abstract][Full Text] [Related]
13. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
14. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of insulin-human serum albumin conjugates.
Thibaudeau K; Léger R; Huang X; Robitaille M; Quraishi O; Soucy C; Bousquet-Gagnon N; van Wyk P; Paradis V; Castaigne JP; Bridon D
Bioconjug Chem; 2005; 16(4):1000-8. PubMed ID: 16029043
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
Jeong JM; Hong MK; Lee J; Son M; So Y; Lee DS; Chung JK; Lee MC
Bioconjug Chem; 2004; 15(4):850-5. PubMed ID: 15264873
[TBL] [Abstract][Full Text] [Related]
17. Site-selective labeling of a lysine residue in human serum albumin.
Asano S; Patterson JT; Gaj T; Barbas CF
Angew Chem Int Ed Engl; 2014 Oct; 53(44):11783-6. PubMed ID: 25196737
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of S-nitrosylated human serum albumin as a novel anticancer drug.
Katayama N; Nakajou K; Komori H; Uchida K; Yokoe J; Yasui N; Yamamoto H; Kai T; Sato M; Nakagawa T; Takeya M; Maruyama T; Otagiri M
J Pharmacol Exp Ther; 2008 Apr; 325(1):69-76. PubMed ID: 18218831
[TBL] [Abstract][Full Text] [Related]
19. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
Govindan SV; Michel RB; Griffiths GL; Goldenberg DM; Mattes MJ
Nucl Med Biol; 2005 Jul; 32(5):513-9. PubMed ID: 15982582
[TBL] [Abstract][Full Text] [Related]
20. Immunologic specificity of IgG against trimellityl-human serum albumin in serum samples of workers exposed to trimellitic anhydride.
Gerhardsson L; Grammer LC; Shaughnessy MA; Patterson R
J Lab Clin Med; 1993 Jun; 121(6):792-6. PubMed ID: 8505590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]